Biogen Inc. (BIIB)
NASDAQ: BIIB · Real-Time Price · USD
208.03
-1.20 (-0.58%)
Jul 30, 2026, 4:00 PM EDT - Market closed
Period EndingJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020
Multiple Sclerosis
3.90B4.04B4.04B4.19B4.18B4.23B4.35B4.45B
Multiple Sclerosis Growth
-6.80%-4.34%-7.14%-5.76%-8.10%-8.37%-6.70%-6.60%
Rare Disease
2.21B2.15B2.15B2.17B2.14B2.13B1.99B1.87B
Rare Disease Growth
3.31%0.98%8.37%16.58%17.34%23.36%13.99%4.21%
Other
2.14B2.79B2.77B2.73B2.74B2.59B2.46B2.39B
Other Growth
-21.88%7.87%12.53%14.22%13.22%4.90%-4.87%-10.48%
Biosimilars
701.60M730.50M729.10M761.30M761.10M777.50M793.60M779.80M
Biosimilars Growth
-7.82%-6.05%-8.13%-2.37%-2.11%0.39%3.06%3.07%
Specialized Immunology
127.80M-------
Period EndingJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020
United States
3.81B3.63B3.55B3.46B3.34B3.25B3.24B3.25B
United States Growth
13.99%11.97%9.59%6.39%3.33%1.85%3.05%3.53%
International
3.38B3.51B3.57B3.82B3.87B3.98B3.98B3.96B
International Growth
-12.71%-11.83%-10.18%-3.44%-3.72%-0.65%-3.14%-5.18%
Other
2.89B2.79B2.77B2.73B2.74B2.59B2.46B2.39B
Other Growth
5.41%7.87%12.53%14.22%13.22%4.90%-4.87%-10.48%
Other Geographic
---2.73B2.74B2.59B2.46B2.39B2.42B2.47B2.59B
Other Geographic Growth
---14.22%13.22%4.90%-4.87%-10.48%-2.92%1.98%18.45%